Serum Adiponectin as an Early Marker for Renal Impairment in Patients With Non-alcoholic Fatty Liver Disease.

Early Detection of Renal Impairment in Patients With Non-alcoholic Fatty Liver Disease by Measuring Serum Adiponectin Level.

Early detection of renal impairment in patients with non-alcoholic fatty liver disease and its correlation with serum Adiponectin level.

Detection of serum Adiponectin by ELISA technique using (EIA-3418) KIT, DRG international inc., USA

Inclusion Criteria:

• Patients with fatty liver aged from 18 to 60 yrs either diabetic or not .
• Patient with normal echogenic kidney in ultrasound and eGFR more than 60 mL/min/1.73m2.
• The Control group are completely healthy subjects without any systemic or liver and kidney affection

Exclusion Criteria:

• Patients less than 18 yrs & more than 60 yrs .
• All patients having any other causes of renal and hepatic disease rather than Diabetes and having any other systemic problem.